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Summary: 
 
Extended Stroke Unit Service and Early Supported Discharge.  
Short and Long-term Effects.  
 
 
Background and purpose 
Stroke imposes a considerable burden for patients, their caregivers and the society 
worldwide. It is a challenge to organise the healthcare service that can provide 
effective management of patients who have suffered from stroke. Several trials have 
shown that stroke unit care improves the outcome for stroke patients. More limited 
information exists about the most effective way to organise the follow-up care after 
the acute care in a stroke unit. Stroke patients conventionally receive a substantial part 
of their rehabilitation in hospital or in other institutions that offer 24 hours-stay. 
 
The primary aim of this thesis was to increase knowledge about the organising of 
follow-up care for stroke patients after the acute care in a stroke unit. To achieve this 
we performed a trial to evaluate the short and long-term effects of an extended stroke 
unit service (ESUS), with early supported discharge from hospital, co-operation with 
the primary health care, and more emphasize on rehabilitation at home as essential 
elements.  
 
Methods 
We performed a randomized controlled trial in which 320 acute stroke patients 
admitted to the Stroke Unit at St. Olavs Hospital, Trondheim University Hospital 
were included and allocated either to ordinary stroke unit care (OSUS) (160 patients) 
with further in-patient rehabilitation or follow-up from the primary healthcare service, 
or to stroke unit care with early supported discharge (160 patients). The ESUS 
consisted of a mobile team which co-ordinate early supported discharge and further 
rehabilitation.  
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Included in this thesis are 4 papers based on data from this study population of acute 
stroke patients followed in one year after the onset of stroke. We wanted to compare 
the groups in relation to independency, quality of life (QoL) and resource use and 
costs.   
 
 
• Functional outcome were measured as the proportion of patients who were 
independent as assessed by modified Rankin Scale (RS)(RS<2 =global 
independence) and Barthel Index (BI)(BI>95 = independent in ADL) at 26 
weeks and 52 weeks, the differences in final residence and analyses to identify 
patients who benefited most of an early supported discharge service (paper I 
and II). All assessments were blinded. 
 
 
• The outcome of QoL was measured by the Nottingham Health Profile (NHP) 
at 52 weeks. Other outcomes measured at 52 weeks were differences between 
the groups according to social activity, depression, cognitive function and the 
burden for carers’. (paper III). 
 
 
• The use of all health services during the first 52 weeks was recorded 
prospectively in both groups; its costs were measured as service costs and 
represent a combination of calculated average costs and tariffs. Hospital 
expenses were measured as costs per inpatient day.  The secondary objectives 
were to explore differences in costs between the groups with respect to 
different types of services, time of service delivery and stroke severity (paper 
IV).  
 
 
Results 
• Extended stroke unit service with early supported discharge and co-ordination 
by a mobile team improves functional outcome 6 months and 12 months after 
stroke. The Odds Ratio for independence at one year was 1.56 (95% C.I, 1.01-
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to 2.44). It was most beneficial for patients with moderate stroke (papers I and 
II). 
 
• Extended stroke unit service with early supported discharge can improve long-
term quality of life measured by global NHP. The ESUS group had a 
significant better QoL after one year than the OSUS group (p = 0.048). There 
were no significant differences between the groups in the secondary outcomes 
social activity, depression and cognitive function. The caregivers who got their 
patients early at home did not report an increased burden compared to 
caregivers whose patients became ordinary stroke unit care (paper III).  
 
 
• The length of initial institutional stay (hospital and rehab.clinic) were reduced 
with 40 % for the patients offered extended stroke unit service (18.6 days in 
the ESUS versus 31.1 days in the OSUS) (p=0.032). There was also a 
reduction in average number of total inpatient days during the first year in 
favour of the ESD group (p = 0.012) (paper IV).  
 
 
•  The total health services costs for ESUS was equal or less than costs for 
ordinary care during the first year after stroke. There was a non-significant 
reduction in total mean service costs in the ESUS group (EUR 18937 / EUR 
21824). The service seemed to be most cost effective for patients with 
moderate severity of stroke (23% lower mean costs compared to OSUS). The 
important cost savings caused by reduced length of institutional stay did not 
lead to an increase in costs for home-based rehabilitation (paper IV). 
 
 
 
Conclusion 
An extended stroke unit service with early supported discharge improved functional 
outcome and reduced the length of stay in institutions compared to traditional stroke 
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unit care. It also seems that this service can improve long-term quality of life. The 
costs are equal or less than costs for ordinary care.   
An early, well organised discharge from hospital co-ordinated by a mobile team 
seems to be an important contribution in the treatment of stroke patients and should be 
considered, in addition to organised in-patient stroke unit care, as a part of a 
comprehensive stroke care.    
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1.0   Introduction: 
 
1.1. Stroke Disease 
Stroke is one of the major causes of death and disability in western countries (1-2). It 
consumes about 5% of total health service resources (3), and in addition to the loss of 
function for the patients and the burden for their families, it imposes a considerable 
economic burden on the individuals as well as society worldwide (4-6).  
During the past decade, the interest for and the focus on stroke research and 
development of more effective treatment methods have increased. The question about 
the importance of organizing of stroke care was addressed for the first time in the 
1950’s (7), and as early as in 1962 the first randomised trial on stroke unit care was 
published (8). During the next decades several randomised trials on stroke unit care 
were performed (9). Hospital organisation seems to play an important role, and there 
is strong evidence today that treatment in dedicated stroke units in the acute phase has 
been shown to be clearly superior to treatment in a general ward for several important 
outcomes, e.g. mortality, functional dependency and need for institutional long-term 
care (9-19). There is consensus that Stroke Unit treatment should be the first link in 
the chain of care (20).  
However, the question about the optimal organisation of post-discharge stroke 
rehabilitation has arisen during the recent years, and the answers are still not well 
documented. A few randomised trials of early supported hospital discharge (ESD) and 
further rehabilitation at home have documented benefits, mostly in reduced length of 
hospital stay (21). However, the organisation of the multidisciplinary team and the 
selection of patients in these trials are varying, and there are great differences. There 
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exists today no single recommendation in relation to how to do the follow-up 
rehabilitation in the most effective way.         
The present thesis is based on methods and results from a randomised controlled trial 
of early supported discharge service for patients at the Stroke Unit at St. Olavs 
Hospital, Trondheim University Hospital. We have compared Extended Stroke Unit 
Service (ESUS) with more traditional post stroke treatment on short and long-term 
mortality and disability (papers I and II), quality of life (paper III) and resource use 
and costs (paper IV) during the first year following a stroke. We have also explored 
the association between stroke severity and an eventually benefit of ESUS versus 
Ordinary Stroke Unit Care (OSUS) (paper I, II, IV).  
 
1.2. Epidemiology 
The first population-based stroke register in Norway (22) indicates that we would 
expect about 10000 first ever stroke and 3400 recurrent stroke to occur every year in 
Norway. The incidence of stroke increased exponentially by age, and about 65% of 
the stroke victims were 75 years and older (22). In the future we will expect change in 
the age distribution of the population in Norway and a projected increase in the 
population older than 70 years, caused by the increase in childbirths after the Second 
World War. This will have a major implication for future understanding of the 
epidemiology of stroke, with an expected increase to about 1 million aged 67 and 
older by 2050 (23).  In 2001 the population older than 70 years was about 520 000 
(23). A comparison between Norway and other West-European countries did not 
indicate major regional variations in stroke incidence (24), but the MONICA project 
has reported a higher incidence of stroke among populations in eastern Europe than in 
western Europe (25).  
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The prevalence of stroke is difficult to measure, and the estimates reported in the 
literature vary a lot (26,27). But two well-designed population-based studies 
measuring prevalence in the 90’s agreed well (28,29), with estimates of the 
prevalence rate on 960 per 100 000 in the population aged > 20 years when 
standardized to the entire European population (30). Like the incidence the prevalence 
increases rapidly with age, with an estimated increase from about 1% at age 50 to 
about 10% in the age group over 80 years.  
The mortality rate of stroke per year in Norway based on the national cause of death  
register is approximately 5500 (31), which are 12% of all deaths and the third leading 
cause of death in our country. 
 
1.3. Definition of stroke: 
Stroke is defined according to the World Health Organisation criteria as “Rapid 
developed clinical signs of focal (or global) disturbance of cerebral function, lasting 
more than 24 hours or leading to death, with no apparent cause other than of vascular 
origin (32). 
 
1.4. Definition of a stroke unit 
There exist different definitions and descriptions of what a stroke unit is, but the 
organisation of care for the stroke patients in hospital are common for all of them.    
The Stroke Unit Trialist’s Collaboration (SUTC) defines “stroke unit” as “Organised 
specialists in-patient stroke care”, and divide the way of treatment in 3 different 
categories as a) dedicated stroke units, b) mixed assessment/rehabilitation unit and c) 
stroke team (9). See further description in chapter 2.3. 
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1.5. Definition of early supported discharge: 
The history of the early supported discharge service is short, and the concept seems to 
hold different types of treatment. The services have variously been termed “early 
supported discharge schemes, “accelerated discharge schemes” and “post discharge 
support service”. One of the subgroups in the Cochrane collaboration is the Early 
supported discharge trialists’ (ESDT) (21), set up to compile all information on 
clinical trials according to ESD. They define this system of care as an Early Supported 
Discharge services that try to develop a service that aims to accelerate the discharge 
home of patients already admitted to hospital. The term “Extended Stroke Unit 
Service” used in this thesis has much in common with the definition of ESD-service, 
but our stroke team found this term more adequate to use because not all the patients 
in this trial were discharged directly to home. Some of them were discharged to other 
institutions, but they got follow-up service as well. 
 
1.6. Definition of inpatient rehabilitation 
In-patient rehabilitation in this thesis is defined as rehabilitation that took place when 
the patient stayed in an institution 24 hours a day, i.e. rehabilitation clinic and 
residential institution. 
 
1.7. Definition of outpatient rehabilitation 
Outpatient rehabilitation is in this thesis defined as rehabilitation that took place when 
the patient had their base at home. It represent a group of different out-patient services 
including rehabilitation in a day clinic or adult day care, visits by home nursing 
service, visit to general practitioner, visit to physiotherapist, visit to occupational 
therapist, and visit to speech therapist. 
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2.0   Background 
 
2.1 Generally 
The effectiveness of treatment in stroke units for acute stroke patients is well 
documented and recommended for all stroke patients in our country (31). The first 
stroke unit (SU) in Norway was established at Aker Hospital, Oslo, during 1983 (33). 
The first stroke unit trial to show statistically significant effects on several outcomes 
was published in Trondheim in 1991 (19). This unit was a combined comprehensive 
stroke unit that offered both acute care and rehabilitation (see chapter 2.3.) 
However, the long-term consequences after stroke and the challenges in which the 
subsequent care should be organised, was insufficiently described in the literature 
worldwide when we started planning our trial in 1995. Some trials had focused on the 
opposite alternatives to in-patient care by preventing stroke patients from being 
admitted to hospital by having an alternative “hospital at home” service. This 
treatment did not show benefits (34). Some trials had compared rehabilitation in day 
clinics or in 24-hour institutions with rehabilitation at home (35-39), but only one of 
them documented a significant positive effect of rehabilitation at home (35). Since the 
last part of the 90’s one approach has been to develop services that could accelerate 
the discharge of patients already admitted to hospital. This is the kind of service that 
has been described with different terms, as “post discharge support services”, “early 
supported discharge schemes”, and “accelerated discharge schemes” (21). 
 
2.2. Background for the Extended Stroke Unit Service trial in Trondheim: 
At St. Olavs Hospital, Trondheim University Hospital we already had an evidence 
based stroke unit treatment based on a combined approach focusing both on acute care 
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and on early rehabilitation (19) when we started planning our extended stroke unit 
service trial in 1995. This stroke unit is defined to be one of the units that have 
showed the most convincing results (40) in acute stroke care. Hence, we might be 
allowed to classify the acute treatment as the “gold standard” acute care. However, we 
also knew that the follow-up treatment after discharge from the stroke unit had several 
weaknesses. Searching in the literature about evidence-based management in the 
follow-up of stroke patients showed that further research was necessary.  We designed 
a trial at our stroke unit with the objective to organise the post acute stroke care in a 
better way to improve the patient’s outcome without increasing the use of health 
resources. The extended stroke unit service we established, greatly emphasized the 
post-discharge service, and can be regarded as a further development of stroke unit 
care as illustrated in figure 1.  
 
 
 
 
        Stroke –The chain of care 
 
Diagnosis 
Observation 
Acute treatment 
Acute rehabilitation
Stroke unit
Further rehabilitation 
Further support 
Secondary prophylaxis 
Cooperation: 
Mobile team 
Specialist care 
Primary health care 
 
Acute 
stroke
Follow-up
Active
life 
Trondheim:   Stroke unit trial        The extended stroke unit trial 
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2.3. The stroke unit at St. Olavs Hospital. 
SUTC categorised such a unit as: “a dedicated combined acute / rehabilitation stroke 
unit which accepts patients acutely for acute treatment combined with early 
rehabilitation for a period of at least 1-2 weeks” (9).  
The aim of these combined units is to offer a systematic non-intensive acute care, 
together with an early quite intensive rehabilitation care. In the stroke unit at St. Olavs 
Hospital there is a program for diagnostic evaluation, systematic observation, acute 
treatment and acute rehabilitation. The aim is: “identifying, reducing or solving 
existing problems; discovering the patients’ resources; enhancing recovery; and 
preventing the occurrence of potential problems at different stages of their illness” 
(41). The unit aim to have a holistic evaluation of the patient, and not only focus on 
the focal lesion in the brain. They also have an observation program with repeated 
assessments of neurological deficits and vital signs to receive information about 
eventually changes continuously. The nursing staff works in close co-operation with 
the physiotherapist and the physicians and the staff is educated to carry out the acute 
treatment and rehabilitation plan 24 hours a day.  
Recommendation from “The Stroke Unit Trialist’s in Trondheim” (41): 
 
“Acute stroke patients need acute care and acute rehabilitation, and they need both 
elements simultaneously during the first few hours/days. Hence, a combined SU 
model may be the most appropriate model for effective management of stroke patients. 
The model of a combined unit which is developed in Trondheim has produced some of 
the most favourable results of SU care, and is one of the models which have described 
the treatment and rehabilitation program in most details. This model of SU care may 
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therefore be a possible guideline for other hospitals which are going to establish 
stroke units.”  
The Program for diagnostic evaluation, observation, acute treatment, and acute 
rehabilitation in the stroke unit are shown in table 1. 
 
 
 
 
TABLE 1. Program for diagnostic evaluation, observation, acute treatment, and acute 
               rehabilitation in the stroke unit. 
 
 
 
Time  Diagnosis  Observation Acute treatment  Acute rehabilitation 
 
 
0-72 hours Clin exam.  BP  I.V.saline solution Stimulation 
 CT scan   Heart rate Oxygen   Mobilisation 
 ECG   Temp  Antipyretics  Sitting, out of bed
 Clin Chemistry  SSS   
 Ultrasound  BP  Sec.prophylaxis  Mobilisation 
 Carotid arteries*  Heart rate Early treatment of Training, sitting, 
     complications   walking 
 Heart*   Temp   
 Others*   SSS  I.V.fluid*  Training in ADL 
 Clin.Chemistry 
 
Day 3 – Further investigations  Exam  Further treatment  Further task 
Discharge when necessary  complications  Sec. prophylaxis  oriented training 
SSS and BI Treatment of  Discharge planning 
    Day 7 and  complications 
discharge   
 
 
*Selected patients 
BP indicate blood pressure; CT, computer tomography; SSS, Scandinavian Stroke Scale; ADL, activities of daily 
living; Sec, secondary; Exam, examination; d, day and I.V., intravenous; BI, Barthel Index.  
 
 
Adapted and modified after Indredavik B. Thesis 156. Faculty of  Medicine, NTNU. TAPIR 1999. 
 
 
 
 
 
 
 
 
 
 24
 
2.4. The prepatation of the extended stroke unit service trial 
In 1994 a delegation with clinicians from the stroke unit at St. Olavs Hospital 
travelled to Norrköping in Sweden to see how they treated their stroke patients after 
the acute stage, during transfer from stroke unit to short-term rehabilitation unit or day 
clinic at the same hospital or discharge to home (42,43).  
 
The stroke research group organised a steering committee and a planning committee 
with representatives from our collaborating partners in the primary health care service 
(PHCS) and the different institutions. We established a net of “contact persons” in the 
primary health care system, which were invited to practice at the SU for a period of 14 
days and were “educated” in the holistic way of thinking during seminars. We also 
had a skills upgrading of the personnel in the SU to secure the communication lines 
and the multidisciplinary teamwork. A lot of information and education meetings in 
the municipality and in the institutions at different levels were also a part of the 
preparation and accomplishment in the trial together with an information and status 
book about the trial, which was updated every month during the entire project period. 
The communication between the different health care levels in the “stroke line” were 
emphasised to be of great importance in the trial. 
 
2.5. User survey and pilot study: 
Before the start of the trial, we performed a user survey with stroke patients and 
relatives who was and has been admitted to the stroke unit at St. Olavs Hospital. The 
survey implemented 20 patients, evaluated by structured interview and standardised 
schemes.  
 
 25
The aims were: 
 - To explore the patients satisfaction with the health care service. 
-  To identify eventually change in quality of life after stroke 
- To assess the need for help and support for the patients 
- To use the information to construct an extended stroke unit service for stroke 
   patients. 
Results: 
- 80% of the patients reported reduced QoL after stroke 
- 70% of the patients requested more follow-up from the hospital after discharge 
- 60% of the patients and 70% of their relatives described the transfer from hospital to  
the primary health care service, and in particularly the first time after discharge, as the 
most difficult period. 
- 75% of the patients and their relatives requested more information about their illness 
and the consequences. 
We also carried out a pilot study with 24 patients followed in one month after 
discharge from hospital. In this study the communication program with the PHCS and 
the different evaluation tools were tried out. 
We concluded that the follow-up program for stroke patients living in Trondheim had 
some defects, especially in the difficult transfer from the hospital to the home 
environment, and the survey gave valuable information about important attempts in a 
new chain of care. 
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3.0.  Objectives and hypothesis: 
 
3.1. The main aims of this thesis were: 
 
1.  To construct a stroke service system in co-operation between the Hospital and 
     the Primary Health Care Service.   
 
 
2.  To perform a trial to evaluate the short and long- term effects of an extended  
     stroke unit service co-ordinated by a stroke team compared to traditional stroke 
     care in terms of functional disability and Quality of Life. (paper I, II, III) 
 
 
 3. To assess the resource use and costs of the ESUS compared to the 
     OSUS during the first year post-stroke. (paper IV) 
 
 
5. To be able to make guidelines about effective organisation of follow-up stroke 
care after discharge from hospital.          
 
 
 
 
 
 
 3.2. Hypothesis: 
 
The trial was designed to test the following hypothesis: 
 
1. Early supported discharge from hospital coordinated by a mobile stroke team, 
with focus on home-based rehabilitation and co-operation with the Primary 
Health Care Service System, improve functional outcome for stroke patients. 
 
2. Rehabilitation and training at home or in day clinics are more effective for stroke 
patients than 24-hour inpatient rehabilitation in a clinic, if the patient does not 
need continuous care and support 24 hours a day. 
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4.0.  Patients and methods: 
 
4.1. Study population  
During the period February 1995 to July 1997, 468 patients from the city of 
Trondheim, aged 60 years or older with acute stroke admitted to the Stroke Unit at St. 
Olavs Hospital in Trondheim were screened for inclusion in the trial. The inclusions 
were stopped two months during summer each year. Hence, the total time of inclusion 
was 24 months. Most of the patients below 60 years (that represent about 10% of the 
stroke patients) were admitted to another department at our hospital and were not 
available for inclusion in this trial. 
The criteria for inclusion were chosen with the main aim to investigate an as 
unselected population as possible, and all patients with sign and symptoms of acute 
stroke according to the WHO definition (32) were screened for inclusion.  
The reasons for exclusion (148 patients) were: SSS < 2 or SSS>57  (105 patients); 
onset of symptoms more than 7 days before the screening for inclusion (14 patients); 
admission to the unit more than 72 hours before the screening for inclusion  (3 
patients); included in other trials (12 patients); admitted from nursing homes (4 
patients); no informed consent (10 patients).  
Unconscious patients could not be included because we needed informed consent, and 
patients living in nursing homes were not included because one of the main objectives 
in this trial was to find the proportion of patients able to return to their own homes 
after their stroke.  Inclusion criteria and reasons for exclusion are also shown in figure 
2. 
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Fig 2 
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The original randomised design was the base for meeting the aims and testing the 
hypothesis. The 320 patients included in the trial, were all included in the “intention 
to treat analyses” (described in chapter 4.4.3.1) (paper I, II, IV). The 258 patients with 
measures on QoL after 52 weeks were included in the “on treatment analyses” (paper 
III). The baseline characteristics are shown in table 2, and the proportion of patients 
in different treatment groups by severity in table 3. 
 
 
 
TABLE 2. Baseline characteristics¹ of the patients allocated to the Extended 
Stroke Unit Service (ESUS) and to the Ordinary Stroke Unit Service (OSUS). 
 
 
 
             ESUS       OSUS       
Characteristic               (n =160)   (n =160)
  
 
Age,y (mean/median)  74.0/74.5      73.8/74.0 
Sex (% female)  46      56 
Living alone (%)  41       43 
Diagnoses (%) 
Nonembolic infarction 68.8              65.0             
Embolic infarction   22.5             23.1 
Hemorrhage                7.5             10.0  
Other                   1.2               1.9 
Medical History (%)    
TIA    13       14 
Stroke    12       16 
Hypertension   33       35 
Myocardial infarction  19       16 
Atrial fibrillation  17        15  
Diabetes   15       12 
Functional state 
SSS*(mean/median)  43.6 / 48.0  43.2 / 47.0 
BI†   (mean/median)  60.4 / 65.0  58.5 / 60.0 
RS‡  (mean/median)   3.3 / 4.0  3.4 / 4.0 
 
 
 
* SSS = Scandinavian Stroke Scale was assessed at inclusion before randomization 
† BI = Barthel Index was assessed within 24 hours after randomization 
‡ RS = Rankin Scale was assessed within 24 hours after randomization 
¹ No significant differences between the groups in baseline characteristics 
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TABLE 3.  Proportion of patients in the two treatment groups by severity of  
                    stroke at baseline¹. 
 
 
 
ESUS (%)  OSUS (%) 
n=160   n=160 
 
Mild      
Baseline SSS 53-58      39   (24.4)     38   (23.6) 
    
Moderate       
Baseline SSS 40-52       81   (50.6)     74   (46.4) 
 
Severe        
Baseline SSS <40         40   (25.0)     48   (30.0)  
 
   SSS indicates Scandinavian Stroke Scale 
¹ No significant differences between the groups 
 
 
 
 
 
 
 
 
4.2. Study design and randomisation procedures 
We wanted in this trial to evaluate the short-term and long-term effects of acute stroke 
unit care combined with early supported discharge in a scientific way. The design was 
strict experimental and had a prospective randomised controlled design (44-46) as 
illustrated in figure 2. After consent, randomisation was restricted in permuted blocks 
with random numbers tables provide in sealed opaque envelopes. The size of the 
blocks was 6, 8 and10 and the sequences of the different blocks where unknown to all 
the trialists. Another department at the St. Olav’s University Hospital in Trondheim 
organised the entire randomisation and inclusion procedure. They generated the 
allocation sequences and assigned the participants to their groups. No stratification 
was used. Independent and blinded assessors specially trained in the use of all the 
outcome measures performed the assessments at 6 weeks, 26 weeks and 52 weeks. 
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4.3. The mobile ESD team 
The mobile team (MT) in the present trial was specially designed to organise the 
follow up, cooperate with the PHCS and to offer support during the first period after 
discharge from the stroke unit. They were responsible for making an as “seamless 
transfer” as possible between the different stages in the health care service. The team 
was hospital-based and was defined as a coordinated multidisciplinary ESD team 
(21). They were represented in all stages in the chain of care (figure 3), either the 
patient was discharge to home, rehabilitation clinic or nursing home, and were 
responsible to establish a service and support system that allowed the patient to live at 
home as soon as possible, if possible. Most of the service after discharge was offered 
by trained staff in the community healthcare system, coordinated by the mobile team. 
For some patients with more extensive needs, the team offered training and support in 
addition to service from other agencies. The team consisted of a nurse, an 
occupational therapist, a physiotherapist and part time service of a physician. They 
also had access to speech therapy. One of the therapists acted as a key worker (case-
manager) and was responsible for the patient and in between the team they used each 
other’s qualifications to solve current problems and challenges. The main points in the 
ESUS and the duty assignment for the mobile team are shown in figure 4 and further 
described in paper I and II.  
 
4.4. The organisation of care for ESUS and OSUS in the stroke unit. 
All patients in both groups were offered the “gold-standard” treatment in the Stroke 
Unit (19). When the patient arrived, the different members of the stroke team in the 
unit did the diagnostic and functional evaluation immediately. The acute team was a  
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Figure 4: The intervention line for the Extended stroke unit service (ESUS) 
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 Figure 3. The mobile ESD team in the chain of  care. 
Randomisation to the ESUS 
Collection of basic information 
Visiting at home / making plans 
Discharge from the stroke unit 
Follow up rehabilitation program 
Outpatient clinic 4 weeks after discharge 
Education meeting 3 months after discharge 
“Active Life” The mobile 
ESD team 
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small one consisting of a stroke nurse, a physiotherapist responsible for the 
mobilisation / training program and a physician. The team had the first day an “acute 
– meeting” to plan the initial treatment. A multidisciplinary “planning-meeting” took 
place once a week, to decide the further treatment and rehabilitation program for the 
patients and the level of service needed. A discharge meeting with patients and their 
relatives was arranged before they left the stroke unit. The initial treatment was the 
same for both groups, as previously described. However, some differences existed 
because the MT started their work as soon as the patient was included in the trial. This 
contact in the stroke unit consisted of collecting basic information from the patient 
and their relatives, explaining their role to the patients, organizing contact with the 
PHCS and starting to plan the further follow-up as early as possible.  
 
4.5. Treatment program for the OSUS 
The patients in the OSUS group were offered the standardized treatment for stroke 
patients in our stroke unit, which has shown to be very beneficial, compared to 
treatment in general medical ward (19,47-50). OSUS could be defined as acute stroke 
treatment according to evidence-based recommendation (9). After discharge from the 
stroke unit, the PHCS were responsible for all the further follow-up. The 
communication between the Hospital and the PHCS varied a lot, from satisfactorily in 
some situations to insufficient in other. Traditionally the patients were discharged 
either to further in-patient rehabilitation or to their homes, with a relative great 
importance to in-patient rehabilitation. They got the follow-up, which until then had 
been the standard way of treatment after discharge from SU in our municipality as 
well as in other Norwegian municipalities.  The differences between the follow-up for 
the ESUS and OSUS are illustrated in figure 5. 
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Figure 5: Study Design II for the Extended stroke unit service (ESUS) and the 
                Ordinary stroke unit service (OSUS). 
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4.6. Treatment program for the ESUS 
The patients in the ESUS were offered the same standardised stroke unit treatment as  
the patients in the OSUS in the acute stage. As described in chapter 4.4, the team 
started their work as soon as possible after the inclusion. Concrete communication 
lines and follow-up schemes with control routines were developed, with the intention 
to optimise recovery, shorten the need for institutional care and reset the patient to an 
active life at home as soon as possible. An organised planning together with the 
patient, relatives, staff in the stroke unit and the PHCS made the basis for the further 
follow-up. The aim was to get a possibility to “manage” the resources and offers to 
the patients who needed it most at the time when they needed it. The idea was that to 
give priority in the initial phase would give patients and relatives a substantial secure 
platform and less need for help later.   
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At least one home-visit during the first week was a part of the intervention for most of 
the patients (80%). For a few patients with the most severe stroke, it was not possible 
to perform a home-visit during the first acute stage. They had to wait until the patients 
were medically stabilised.   
The intention with this early visit was to get a picture of the scope of the necessary 
rehabilitation process, to be able to put the aims in concrete terms, and to motivate 
patients and relatives to see the possibilities in an enriched environment.  
A “seamless transfer” between different areas in the health care service was 
emphasised to aspire to a more continued rehabilitation process. The patient never left 
the Hospital or Rehabilitation clinic without a companying person (the key worker) 
from the MT, which could bring the necessary medical information and aims for the 
further action program directly to the personal at the next step in the chain of care.  
One month after discharge from Hospital or Rehabilitation clinic we try to phase out 
the close relationship between the patient and their key worker in the MT, among 
other factors to avoid an addiction problem. We also emphasised for the patient and 
their relatives the importance to return to the daily routine and being a “person” rather 
than a “patient” after a period. Further details of the intervention are described in 
paper I. 
 
 
4.7. Assessments of outcome  
The International Classification of Impairments, Disabilities and Handicaps (ICIDH) 
was published in 1980 (51) as a model of systematic classification of illness and 
functioning in order to classify and categorize the data that may be collected, and 
measure the results. This system has recently been revised, and the overall objective is 
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to provide a standardised vocabulary for the description and for research of health 
outcomes in terms of body, person, or social function (52). The ICIDH offers an 
important theoretical perspective to research, although it has been said to have 
weaknesses, especially to the concept of quality of life (53).  The term “functional 
outcome” which is often used in this thesis is not described by the ICIDH. We have 
used the term according to ADL (Barthel Index) and Rankin scale, as a term of 
disability.   
In general there has been little consistency and no consensus to how the outcome of 
stroke should be measured (3), even though it is developed a number of stroke scales 
for use in clinical trials (54). That complicates the interpretation of the results and the 
comparison between studies. The main issue is, however, to choose instruments in 
accordance with the research question and consistent with the aims of the intervention 
or treatment to be evaluated. Consistency in the use of appropriate measures of 
outcome, the methods of analyses and the timing of measurements would have many 
benefits for the stroke research (55). Continued use of several of instruments that may 
not be specific or sensitive enough may result in more questions than answers, and 
may easily become an obstacle to further research.  
When we started the trial and decided which outcomes that were relevant to choose, 
we did not have many references in this field, because the history of ESD research 
was short. However, we had experience from a randomised controlled trial (RCT) for 
stroke patients (41) and wanted a continuance, if possible, of some of the scales 
measurements that already were chosen and well known at the stroke unit. Some 
guidelines are essential when choosing outcomes tests and scales. The evidence of 
reliability and validity is vital for all outcome measures, to ensure confidence in their 
scientific robustness (56). The reliability of the tests is a measure of to what degree 
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the data are identical if they are sampled repeatedly under the same conditions (57), 
and should be emphasized. The validity is the degree to which the measure reflects 
what it is intended to measure (3), and important in this kind of trials. The validity of 
this thesis will be further described in chapter 6.2. The power, which refers to the 
ability to identify differences between the groups, (3) is also important. The fact that 
the tests had to be easy to complete for the patients was essential in our trial, and the 
practical usefulness for the clinician was also something we had in mind. 
Measures like mortality, morbidity, recurrence, length of stay in hospital and 
measures of activity in different forms are frequently used in stroke research (58,59). 
The methods used for evaluation and the point in time for the different assessments 
are shown in table 4. 
According to primary and secondary outcome scales in this thesis, our use of primary 
outcome in the different papers may lead to some confusion. The main primary 
outcome of the trial was modified Rankin Scale (mRS) (60) and Barthel Index (BI) 
(61) at 26 weeks (paper I), which means that the power calculation was based upon 
this primary outcome. We have used the modified Rankin Scale at 52 weeks as the 
primary functional outcome in the long-term analyses (paper II). The Nottingham 
Health Profile (NHP) (62) was the primary outcome of long-term Quality of Life 
(paper III).  
For the modified Rankin Scale and the Nottingham Health Profile at 52 weeks we 
made no power calculations and we are aware that the use of the term “primary 
outcome” in these follow-up analyses might be questioned. We wanted a hierarchical 
structure of the analysis also in the follow-up analysis, and that is why we have used 
the term “primary outcome”. All the analyses at 26 and 52 weeks were pre-defined  
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and described in the protocol, except the sub-group analysis at 26 weeks for patients 
with moderate and severe stroke at baseline (SSS >2 and < 52).  
 
4.7.1. Primary outcomes scales 
Barthel Index (BI) was developed in 1965 (61), and later modified as a scoring 
technique that measures the patient’s performance in ten activities of daily living (63). 
It is the most commonly selected measure of basic activities of daily living in stroke 
research today (3,64,65). BI is an ordinal scale with maximum score of 100, and it is 
considered to have good reliability and validity (56,64,66). The reliability is known to 
be high even when data are collected by indirect observation (67). The score 
associates to many other measures such as stroke severity, social activities and 
mortality, so the index also has predictive and concurrent validity (68). The index is 
not very precise, but quite sensitive to detect improvement. A problem with this scale 
is the insensitivity to small changes in functional status, and its significant ceiling-
effects (65,69). That may represent a problem in long-term follow up trials (as in 
paper II in this thesis) and in measurements of patients with mild stroke. Although the 
BI is the most common measure, the cut-off scores used to differentiate outcomes are 
recorded to be defined in 7 different ways (55,70,71). However, according to Duncan 
et al (55), the cut off point >95 (as used in paper I and II) is together with cut off 
point > 60 the most frequently used in stroke studies. The BI is used as primary 
outcome measure in paper I and as secondary outcome measure in paper II. 
 
Rankin Scale (RS) (60) is another of the most frequently used scale to assess 
functional outcome and disability in clinical stroke trials. Initially, the scale consists 
of 5 grades, from 1 to 5, with 1 corresponding to no symptoms and 5 corresponding to 
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severe disability.  The scale has the two great virtues of simplicity and reliability 
making it ideal for many trials (72,73). It is also validated (55). The criticism about 
this scale is that it is inherently insensitive, it mixes objective and subjective items and 
it spans impairment, disability and handicap (64,69). The modified version of the RS 
is called mRS and consists of 6 grades including a class for “death”. The modified 
Rankin Scale (mRS) is widely used to assess global outcome after stroke. 
Dichotomising scales as in this thesis with mRS < 2 defined as favourable outcome 
are commonly used and have many advantages, but is also criticised for reducing the 
outcome information and may limit the ability to detect a significant shift in disability 
(55,74). The inter-rater reliability of the mRS is not shown to be substantial (75). The 
mRS is used as primary outcome measure in paper I and paper II. 
 
Quality of Life 
QoL has been defined by the World Health Organization Quality of Life Group 
(WHOQOL) as “individuals’ perceptions of their position in life in the context of the 
culture and value system in which they live and in relation to their goals, expectations, 
standards and concerns” (76). In stroke research, assessment of quality of life is 
becoming increasingly common the recent years, and there has been focused on the 
necessity of using QoL assessments to get a clear and comprehensive evaluation of 
efficacy in different stroke trials (69,77,78).  
It has been difficult to agree on a uniform way to measure Quality of Life for stroke 
patients, and no single measurement scale is developed. The lack of general 
agreement for standardized methods for QoL assessment in stroke patients is a 
difficult challenge. The concept of QoL is not clearly defined (65). Some define QoL 
as the patients’ own perception, satisfaction and well being (79,80), and other has a 
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more health related approach (81).  Hence, it seems that a multidimensional approach 
comprising 3 broad domains (physical, mental and social) is important (48,82-84).  
The evidence of validity and reliability should be the first considerations, together 
with appropriateness and comprehensiveness (78).  
 
The Nottingham Health Profile scale (NHP) (62) was used to assess quality of life 
at one year in this thesis. The NHP measures emotional, social and physical distress. It 
quantifies health status and has been used for the general evaluation of health or 
health-related QoL. It emphasizes subjective aspects of health assessment. NHP part 1 
contains 38 items in six sections: pain, emotional reactions, sleep, physical mobility, 
social isolation and energy level.  Each item reflects departures from normal and the 
items are weighted to reflect their importance. Part I of the NHP forms a profile of six 
scores corresponding to the different sections of the questionnaire, and there is no 
single summary index. Each component is weighted to give a score 0-100 (85). 
Part II of the Profile relates to seven areas of task performance most affected by 
health. This section has no weights but a summary statistic. These data are of more 
limited use. We have also used a global NHP score (86). The use of this total 
summary score can be discussed (3), but it may give some important information 
about the total life situation for the patient. 
When we started planning this trial in the 90’s, this scale was the most frequently used 
in stroke trials. Today, more systematic reviews and knowledge have been published 
according to the different qualities of different outcomes scales (57,78,84) and we 
might would have considered choosing another scale. The NHP was used as primary 
outcome measure in paper III and the advantages and disadvantages with the NHP are 
discussed in this paper.  
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4.7.2. Secondary outcomes scales. 
Proportion of patients at Home, in Institution and Diseased.  
The differences between the groups in the proportion of patients at Home, in 
Institution and Diseased after 26 weeks (paper I) and after 52 weeks (paper II) were 
used as secondary outcomes together with the differences in length of stay in 
institutions (paper I). Indirectly, it says something about the patient’s disability, but 
we preferred to use the BI and mRS as a more directly measures on functional ability 
and activities of daily living as the primary outcomes.  
The length of stay in institutions were measured as length of inpatient stay before 
discharge to final residence, which means that at the day when a patient for example 
were decided to live permanently in a Nursing Home, we ended the registration. The 
length of “institutional stay” presented in papers I and II, included the initial hospital 
stay and initial stay in rehabilitation clinic. The “discharge day” from hospital was not 
included in the initial hospital length of stay. In the “length of inpatient rehabilitation” 
presented in paper IV the residential institution and readmissions in rehabilitation 
clinic were supplemented. The registration started at the day of admission to hospital, 
and not at the day of inclusion in the trial. The date of transfer from one “care level” 
to another was recorded at the place the patient was discharged from (paper IV). The 
data on length of stay in hospital and other institutions were recorded during data 
registration program at the hospital and monthly reports from the other institutions. 
The deaths were recorded during a monthly death reports from the municipality 
Registry Office.  
 
The Frenchay Activity Index (FAI) (87) has been developed specifically for stroke 
patients, and according to the ICIDH-2 (50,51), the FAI reflects aspects of activities 
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(disability) and also of participation (handicap). It measures more complex physical 
activities and social functioning with a score for each of the 15 items (max score 60). 
It exhibits reliability and validity and has been shown to be responsive to change (78). 
It can be both self-and interviewer-administrated, and also the inter-rater reliability 
between patients and relatives has been evaluated as good (88-90). The scale has also 
been used to measure QoL for stroke patients, and it is a stroke-specific measure that 
can be used to successfully assess QoL with proxy respondents (78). The FAI is used 
as secondary outcome in paper III. 
 
 The Montgomery - Åsberg Depression Scale (MADRS) (91) is a rating scale for 
mood disorders. It consists of 10 items (0-6) and avoids emphasis on somatic 
symptomatology. The scale has the considerable advantage of brevity and ease of 
administration (92). The scale exhibited construct and concurrent validity (93). The 
MADRS was used as secondary outcome in paper III. 
 
The Mini Mental State Examination (MMSE) (94) is a simplified scored form of 
the cognitive mental status examination and includes eleven questions and a sum 
score of 30.  The domains including orientation, registration of words, attention, 
calculation, recall, language and visual construction. The test is widely used for 
screening, but is criticised for may misclassify patients with aphasia (95). The test is 
provided to be reliable and valid. It is useful in quantitatively estimating the severity 
of cognitive impairment, in serially documenting cognitive changes. The MMSE was 
used as secondary outcome in paper III. 
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The Caregivers Strain Index (CSI) (96) is a validated 13 items strain index 
developed to measure the burden of the patient’s illness on the caregiver. High score 
indicated a low level of burden, and the score ranges from 13 to 26. CSI is a brief, 
easily administrated instrument that identifies strain of informal care providers. The 
CSI was used as secondary outcome in paper III. 
 
The Scandinavian Stroke Scale (97) was used to quantify neurological dysfunction 
in this trial. The scale are frequently used in stroke trials to assess the primarily body 
function or impairment, to quantify neurological deficits, to measure recovery, 
predicting outcome and to compare stroke severity of patient groups at baseline 
(97,98). The SSS contents of 2 parts, a prognostic score and a long-term score. We 
used the total score, which included the items from both the prognostic score and the 
long-term score and consist of 9 items and a maximum score of 58 (99). SSS is simple 
to use and the validation and reliability are quite high. (54,70,97,98,100). The scale 
was used to assess the severity of stroke at baseline in our secondary analyses (paper I 
and II). 
 
4.7.3. Assessments of resource use and costs  
The resource implication and costs of the ESD-service are important in relation to 
how relevant the service is to take into use. Stroke imposes a considerable economic 
burden on the society and the costs are of vital importance for making decision about 
use of different treatment methods. 
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Resource use: 
We recorded all the different types of inpatient and outpatient health services the 
patients in this trial received in the period from inclusion to one year after inclusion. 
The different services recorded are listed in paper III (table 1). The type, frequency 
and number of services were recorded during “health service registration cards” 
given to the patients, their family and their health workers each month (appendix 2). 
They had the responsibility to filled them out exact each time they were offered some 
of the services. The study group developed these registration cards, because we could 
not find this type of prospective registration system used in other stroke trials.  As a 
security system we used the data registration system in the primary health care system 
(GERIX) (101) when available. The length of institutional stay was recorded as 
described in chapter 4.7.2.  
 
Costs 
An independent research institution in Norway, SINTEF Health Research, calculated 
the costs of all types of health services recorded in the trial. The work was 
complicated because the different institution did not have exact information about the 
unit costs and for some health services they had to find national costs estimates. We 
chose to use estimates of average costs per service type, a so-called “gross-costing” 
(102) rather than a detailed micro costing of services. Costs were measured as service 
costs, which mean a combination of tariffs and calculated average costs. The cost is 
presented as total mean services costs for all 320 patients.  
We categorized the different types of the 15 health services into six groups as follows: 
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1) Acute care costs represent the costs for the initial stay in the stroke unit. It was 
measured as cost per inpatient day, and adjusted for the patients Diagnoses Related 
Group (DRG). A Diagnosis Related Groups specific cost is available in Norway, and 
these DRG’s are used as the basis for hospital financing. This cost is thus a national 
average cost. (Our stroke unit has been one of the departments where these national 
DRG cost estimations have been performed.)  
2) Acute care readmissions costs represent all readmissions to hospital (independent 
of reason) during the first year post stroke, and were measured in the same way as the 
acute care costs. 
3) Inpatient rehabilitation costs represent the costs for inpatient care in 
rehabilitation clinic or in residential institution. Detailed cost data for this service 
were available. 
 4) Home-based rehabilitation costs represent a group of different outpatient 
services including rehabilitation in a day clinic or adult day care, visits by home 
nursing service, use of general practitioner, physiotherapist, occupational therapist, 
speech therapist and use of automatic warning aid. Tariffs were used for some of these 
services, when detailed costs were not available.  
5) Permanent institutionalisation costs represent the costs for the group of patients 
who were discharged to a nursing home or another form of “assisted living”. The 
costs calculated for a nursing home were detailed costs while the other was tariff cost.  
6) The mobile team costs. 
The estimated total costs of the mobile team are defined and recorded as wage costs 
per year for the four members of the team. 
The mobile team costs in the analyses are overall costs measured as a total sum for 
each patient during the first year in the ESUS group, and are the same for each 
 47
patient, regardless of whether they have had more or less service from the mobile 
team. We do not have good enough information to select the costs for each patient, 
but these costs represent a small proportion of the total costs, and we do not think it 
will have any important influence of the results. In the sub-analyses of costs stratified 
in time periods (paper IV) we have entered the mobile team costs in the first 6 weeks 
based on the most intensive intervention period.  
 
4.8. Statistical analysis. 
For the preparation and accomplishment of this trial we have received statistical 
guidance from the Life Insurance Medical Statistic Institute at Ullevål Hospital in 
Oslo. For the preparation of paper II and paper III, we have got statistical guidance 
from Unit for Applied Clinical Research, Faculty of Medicine, the Norwegian 
University of Science and Technology. 
 
4.8.1 Sample size estimation  
The Rankin Scale and Barthel Index 26 weeks after the onset of stroke was the main 
primary outcome in this trial, and the basis for the sample size calculation. With an 
estimated rate of success of 15% (differences between the groups), power 80%, and 
significance level 0.05, we estimated a sample size of 320 patients (45,103). This was 
also the upper size for our ability to run this trial in our centre, because we had some 
limitations on time, funds and admission of patients. When we planned this trial we 
did not have results from other trials, and therefore we had to make our own decision 
about the projected effect of this intervention based on a clinically pragmatic 
approach. Our calculation was partly based on results from the previous acute stroke 
unit care trial (19). 
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4.8.2. Statistics of the baseline data 
The statistical software program used was SPSS 10-7 (SPSS Inc., Chicago, IL). 
Group homogeneity was analysed with the Persons X2 test for category data like 
medical history, sex, distribution of diagnoses and living condition.  
Mann-Whitney U test (non-parametric test) was used to compare the groups for 
variables not normally distributed, as age and severity of stroke according to the SSS-
score at baseline and the differences in BI and RS assessed within 24 hours after 
randomisation (61). The significance level for all the analyses in this trial was set to 
0,05. 
 
4.8.3. Statistical evaluation of outcomes 
 
4.8.3.1. Intention to treat analyses 
The intention to treat (103) population was used in all the main analyses on the 
categorized BI and mRS (paper I-II). If a patient had a missing last value on BI or 
mRS we used all other available information to calculate their functional level or we 
carried forward their baseline values. All patients had participated in at least 2 
assessments, and with the results from the last assessment, sometimes combined with 
telephone interview and information from readmissions, it was possible to categorise 
quite precisely their functional level.  
Regarding the effect of ESUS compared to OSUS related to long-term QoL, intention 
to treat analyses was not feasible, because the NHP we used as a measure of QoL 
require a minimum of communication with the patients (3,62,104). Hence, for our 
QoL analyses we had to select patients with the ability to speak and to understand. 
(paper III).  
 49
There were no significant differences in the number of patients excluded and the 
missing documentation between the groups. 
 
4.8.3.2. Multiple regression analyses 
We used multivariable regression methods to adjust for differences in baseline 
characteristics between the groups and to analyse the odds ratio (OR) for 
independence. The type of the regression model depends on the distribution of the 
dependent variable (y). The multivariable regression modelling gives the opportunity 
to include and control for variables with potential confounding effects. A confounder 
is a variable that is both associated with the exposure and, independent of that, is 
associated with disease (105). In our analyses confounding is associated with 
outcome, and we have adjusted for confounders because it may influence the 
outcome. Logistic regression is commonly used when the independent variables 
include both numerical and nominal measures and the dependent variable is 
dichotomized (binary) as in our trial.  
In this trial logistic regression were carried out to obtain a more precise estimate of 
the primary outcome mRS at 52 weeks (RS< 2 as dependent variable) (paper II), 
adjusted for potential confounders (106). As independent variables we chose age, sex, 
severity of stroke and cohabiting status because these variables are known to be strong 
predictors of outcome after stroke (107). 
We also used the fitted logistic regression model when we analysed the relation 
between the severity of stroke and the Number needed to treat (NNT) (108) to achieve 
one more independent patient in the ESUS group versus the OSUS group (paper II).  
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4.8.3.3. Cost analyses 
 
Health economy as a discipline represents a complex area and requires qualification 
beyond what is necessary to plan and complete a clinical trial for stroke patients. The 
economic analyses are not a primary outcome in this thesis (paper IV), but an 
important contribution to give a more complete picture of the early supported 
discharge service carried out in this trial. The data on resource use were collected 
prospectively and accurate, and to the calculation of unit costs and the preparation of 
the paper we had contribution from a health economist. 
We have calculated the costs for each patient up to one year or to time of death, and 
then shared the total costs to estimate total average total costs for the patients in each 
group. There was no significant difference in mortality between the groups in this 
trial, and the results of the trial will not be influenced by how we have analysed the 
patients who died.   
 
4.8.3.4. Paper I-IV. 
Paper I-II. 
To investigate any differences between the groups in the primary outcomes mRS and 
BI, we used the Pearsons X2 test because the variables were dichotomized. To 
investigate any differences in the secondary outcomes proportion of patients 
independent, at home, in institution and diseased we also used the Pearsons X2 test 
(109).   
To express the relative benefit of the intervention according to independence we also 
calculated the Odds Ratio (OR), which here is defined as the odds for good outcome 
defined by mRS<2 in the active treatment group divided by the odds for good 
outcome in the control group (103).  The measure has several statistical advantages 
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and is used extensively in epidemiology, but is perhaps not very helpful in clinical 
decision making (108).  
Number needed to treat (NNT) is another measure we used to estimate the effect of 
the intervention. It describes in our trial how many patients that were needed to treat 
in the intervention group to achieve one more independent patient. NNT is becoming 
widely used as a tool for therapeutic decision making the recent years and is 
calculated on the inverse of the absolute risk reduction. It conveys both statistical and 
clinical significance to the health workers (108). The figure 2 in paper II is an 
example of the estimated NNT which may can give information to the clinician in 
relation to predict outcome related to severity of stroke at baseline, or may give 
information about which patients should be given priority from a mobile team.  
For the Logistic regression used, see chapter 4.8.3.2. 
 
Paper III. 
For ordinal scales like NHP, FAI, MADRS, CSI and MMSE, we used the non-
parametric Mann Whitney U test to compare the differences between the groups. In 
the presentation of results on NHP we found it suitable to present the mean values in 
addition to the median values because some of the median values were zero and give 
little information. 
There was no significant difference in mortality between the groups at 52 weeks and 
the drop-outs in both groups were below 5% (6 in the ESUS and 9 in the OSUS), so 
we do not think that will influence any results. Some considerations about the use of 
the “ intention to treatment population” in these analyses are described in chapter 
4.8.3.1.  
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Paper IV 
In the analyses, we used the Mann-Whitney U test to investigate any differences in 
costs between the groups. The cost data were right skewed, which means they were 
not normally distributed (103). A large number of patients had zero cost values, 
because they did not receive all the different health services recorded in the trial. 
Because of the skewed distribution we found it suitable to present the mean values 
instead of the median levels, as described and recommended of Heyse et al. (110). 
We also used simple sensitivity analyses of the most expensive cost components by 
decrease and increase the costs by 25%.  
 
4.9 Funding 
This thesis has been completed while I have been receiving a research fellowship 
from the aid of EXTRA funds from the Norwegian Foundation for Health and 
Rehabilitation. The Norwegian Foundation for Health and Rehabilitation is an 
institution consisting of different voluntary health and rehabilitation organisations, 
which focus towards strengthening the work of voluntary humanitarian organisations 
in preventive health care, rehabilitation and research in Norway.  
The preparation and accomplishment of the trial has been supported by the Norwegian 
Department of Health. The Stroke Unit Fund of Stroke Research, St. Olavs’ Hospital 
in Trondheim also supported the trial. There exists no conflict of interest in this trial.  
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5.  Results 
 
5.1 Review of paper I: 
Benefit of an extended stroke unit service with early supported discharge:  
A randomized, controlled trial.  
Indredavik B, Fjærtoft H, Ekeberg G, Løge A, Mørch B.  
Background and purpose: Several trials have shown that stroke unit care improves the 
outcome for stroke patients. The aim of the present trial was to evaluate the effects of 
an extended stroke unit service (ESUS), with early supported discharge, co-operation 
with the primary health care, and more emphasize on rehabilitation at home as 
essential elements. 
Patients and Methods: In a randomized controlled trial 160 patients with acute stroke 
were allocated to the ESUS and 160 to the ordinary stroke unit service (OSUS). The 
primary outcome was the proportion of patients being independent assessed by the 
modified Rankin Scale (RS)(RS<2 =global independence), and independent in 
activities of daily living (ADL) assessed by Barthel Index (BI)(BI>95 = independent 
in ADL) after 26 weeks (w). Secondary outcomes were RS and BI after 6w, the 
proportion of patients at home, in institutions and deceased after 6 and 26 w and the 
length of stay in institutions.  
Results: After 26 w 65.0% in the ESUS versus 51.9% in the OSUS group showed a 
global independence (RS< 2) (P=0,017), while 60.0% in the ESUS versus 49.4% in 
the OSUS were independent in ADL (BI>95) (P=0.056). The odds ratio (OR) for 
independence (ESUS versus OSUS) were for RS: 1.72 (95%CI:1.10-2.70), and for BI: 
1.54 (95%CI:0.99-2.39). At 6 w 54.4% of the ESUS and 45.6% of the OSUS group 
were independent according to RS (P=0.118), and 56.3% versus 48.8% independent 
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according to BI (P=0.179). The proportion of patients at home after 6w were 74.4% 
(ESUS) and 55.6%(OSUS) (P=0.0004), and in institutions 23.1% versus 40.0% 
(P=0.001).  After 26 w 78.8% in the ESUS group versus 73.1% in the OSUS were at 
home (P=0.239), while 13.1% versus 17.5% were in institutions (P=0.277). The 
mortality in the two groups did not differ. Average lengths of stay in institution were 
18.6 days in the ESUS and 31.1 days in the OSUS group (P=0.0324). 
Conclusion: An extended stroke unit service with early supported discharge improves 
functional outcome, and reduces the length of stay in institutions compared to 
traditional stroke unit care.   
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5.2 Review of paper II: 
 
Stroke Unit Care combined with Early Supported Discharge. Long Term follow-
up of a Randomized Controlled Trial. 
Fjærtoft H, Indredavik B, Lydersen S. 
 
Background and Purpose: Early supported discharge from a stroke unit reduces the 
length of hospital-stay. Evidence of a benefit for the patients is still unknown. The 
aim of this trial was to evaluate the long-term effects of an extended stroke unit 
service (ESUS), characterised by early supported discharge.  
Methods: A randomised controlled trial where 320 acute stroke patients were 
allocated either to ordinary stroke unit care (OSUS) (160 patients) or stroke unit care 
with early supported discharge (160 patients). The ESUS consists of a mobile team 
which co-ordinates early supported discharge and further rehabilitation. 
Primary outcome was the proportion of patients who were independent as assessed by 
modified Rankin Scale (RS)(RS<2 =global independence). Secondary outcome 
measured at 52 weeks was Barthel Index (BI)(BI>95 = independent in ADL), the 
differences in final residence and analyses to identify patients who benefited most of 
an early supported discharge service. All assessments were blinded. 
Results: 56.3% of the patients in the ESUS versus 45.0% in the OSUS were 
independent (RS< 2) (p=0.045). NNT to achieve one independent patient in ESUS 
versus OSUS was 9. The odds ratio (OR) for independence was 1.56 (95%CI: 1.01-
2.44). There were no significant differences in BI and final residence. Patients with 
moderate to severe stroke benefited most from the ESUS. 
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Conclusion: Stroke service based on treatment in a stroke unit combined with early 
supported discharge improves the long-term clinical outcome measured by modified 
Rankin Scale compared to ordinary stroke unit care. Patients with moderate to severe 
stroke benefit most. 
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5.3 Review of paper III: 
 
Acute stroke unit care combined with early supported discharge. Long-term 
effects on quality of life. A randomized controlled trial.  
Fjærtoft H, Indredavik B, Johnsen R, Lydersen S:  
 
Objectives: The aim of the present trial was to compare the effects of an extended 
stroke unit service (ESUS) with the effects of an ordinary stroke unit service (OSUS) 
on long-term Quality of Life (QoL).  
Design: One-year follow-up of a randomized controlled trial with 320 acute stroke 
patients allocated either to OSUS (160 patients) or ESUS (160 patients) with early 
supported discharge and follow-up by a mobile team. The intervention was a mobile 
team and close co-operation with the primary health care service. All assessments 
were blinded. 
Main outcome measure: Primary outcome of  QoL in this paper was measured by the 
Nottingham Health Profile (NHP) at 52 weeks. Secondary outcomes measured at 52 
weeks were differences between the groups measured by the Frenchay Activity Index, 
Montgomery-Åsberg Depression Scale, Minimental State Score and the Caregivers 
Strain Index.  
Results: The ESUS group had a significant better QoL (mean score 78.9) assessed by 
global NHP after one year than the OSUS group (mean score 75.2) (p = 0.048). There 
were no significant differences between the groups in the secondary outcomes, but a 
trend in favor of ESUS. Caregivers Strain Index showed a mean score of 23.3 in the 
ESUS group and 22.6 in the OSUS group (p= 0.089). 
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Conclusion: It seems that stroke unit treatment combined with early supported 
discharge in addition to reducing the length of hospital stay, also can improve long-
term QoL. However, other similar trials are necessary to confirm the benefit of this 
type of service. 
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5.4 Review of paper IV: 
 
Early Supported Discharge for Stroke Patients Improves Clinical Outcome.  
Does It Also Reduce Use of Health Services and Costs?  One year 
follow-up of a randomised controlled trial. 
Fjærtoft H, Indredavik B, Magnussen J, Johnsen R.  
 
Background: An early supported discharge service (ESD) appears to be a promising 
alternative to conventional care. The aim of this trial was to compare the use of health 
services and costs with traditionally stroke care during a one-year follow-up.   
Methods: 320 patients were randomly allocated either to ordinary stroke unit care 
(OSUS) or stroke unit care combined with ESD that was coordinated by a mobile 
team. The use of all health services was recorded prospectively; its costs were 
measured as service costs and represent a combination of calculated average costs and 
tariffs. Hospital expenses were measured as costs per inpatient day and adjusted for 
the DRG.  
Results:  There was a reduction in average number of inpatient days at 52 weeks in 
favour of the ESD group (p = 0.012), and a non-significant reduction in total mean 
service costs in the ESD group (EUR 18937 / EUR 21824). ESD-service seems to be 
most cost effective for patients with a moderate stroke.    
Conclusion: Acute stroke unit care combined with an ESD-program reduces the 
length of institutional stay without increasing the costs of outpatient rehabilitation 
compared to traditional stroke care.   
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6.0 General discussion  
 
  6.1. Methodological considerations 
In this trial we have tried to follow the procedures according to good clinical practice 
and ethical principles for medical research described in the Declaration of Helsinki 
(111). Randomised controlled trials are usually taken as the “gold standard” against 
which to judge the quality of the design of a trial (103). The randomisation is a 
method of eliminating bias in the way that treatments are allocated to patients, and the 
key of a successful clinical trial is to avoid any biases in the comparison of the groups. 
Random allocation is crucial to ensure comparability among groups and provide 
reliable answers. The randomisation deals with possible bias at the treatment 
allocation, but bias can also creep in while the study is being run. Therefore a blinded 
evaluation is also necessary (103). In our trial neutral assessors (physiotherapists) 
specially trained in the use of the outcome measures performed all the assessments. 
The blinding procedure is not simple in this kind of trials, but the evaluation was 
blinded as far as possible. The strength of the blinded evaluation procedure is unclear, 
and we have not performed any evaluation of the efficacy of this blinding procedure. 
However, this trial has been mentioned from the leader of the SUTC (112-comment) 
to have high methodological quality.  
  
Randomly allocation does not guarantee that the characteristics of the different groups 
are similar, but in our trial there were no significant differences between the groups in 
baseline characteristics (table 2). There was a trend towards sex differences between 
the groups at baseline with a pre-dominance of men in the ESUS group (54% against 
44%), which could have caused a bias. A Swedish study recently has shown women 
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to have a worse post stroke condition than men (113) while other trials has shown that 
sex has no influence on outcome (114). However, since differences at baseline 
between the groups were not significant, we did not find it necessary to take that into 
account.  
The distribution of the severity of stroke was the same in both groups at baseline 
(table 3), and table 5 shows that there were no significant differences between the 
groups at discharge from hospital although the destination were different. But there 
was a reduction in both groups according to the number of patients with severe stroke 
(16% in ESUS, 19% in OSUS) at the time of discharge. Most of the other ESD trials 
included the patients about the time of discharge from hospital, and excluded patients 
that were not able to transfer independently or by resident carer (115), had moderate 
disability (116) or intact cognition (37). The meta-analysis from Langhorne et al (117) 
showed a median proportion of patients eligible for ESD services of 41% (range 13-
68). We included 68 % in our trial, and had a quite more unselected population than 
the other trials in the field. 
 
 
TABLE 5.  Proportion of patients in the two treatment groups by severity of 
                    stroke¹ at discharge from Stroke Unit 
 
 
ESUS (%)  OSUS (%) 
n=156  n=155   
 
Mild      
SSS 53-58       70   (44.9)     69   (44.5) 
    
Moderate       
SSS 40-52       61   (39.1)     57   (36.8) 
 
Severe        
SSS <40           25   (16.0)     29   (18.7)  
 
SSS indicates Scandinavian Stroke Scale 
¹ no significant differences. 
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A limitation with this kind of methodology used in our trial, is that we do not know 
exactly why the present service system works so well. It may be different factors that 
plays important role, and to identify the most important components might be a 
challenge for the future. Enriched environment is shown to be important for better 
outcome in animal studies (118), and rehabilitation at home may have a lot of gains 
(115,119). Physical and psychosocial elements of the environment influence the 
patients’ ability to perform desired activities and attain targeted levels of participation 
during rehabilitation (120,121). 
A couple of studies from rehabilitation in institution have shown that not much of the 
time was occupied by training (122,123). It also may be an explanation that training in 
institution has a low degree of transmission to functioning at home (124).     
The description and discussion about the test instruments we used for the primary and 
secondary outcomes are described in chapter 4.7, and will not be repeated here. 
 
From a methodological point of view it is a challenge to compare trials measuring 
resource use and costs for stroke patients (paper IV). There are big differences in how 
each component of health care are valued, how and when the costs are measured, 
which costs items are included and how costs are estimated and concerning the time 
period in which the resource use is recorded.  
In this trial the use of “health service registration cards” which were checked by a 
coordinator each month is a strength, and should be able to give a reliable estimate. It 
is also an advantage that a third party calculated the unit costs. 
In this trial we also have at least three shortcomings. First, we did not have the 
opportunity to include capital costs, and thus underestimate the costs of 
hospitalisation, rehabilitation and nursing homes. Second, although we believe that 
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the costs give an accurate picture of actual treatment costs, deviations from optimal 
efficiency levels may distort them from efficient societal costs.  
Third, we do not include travel costs, losses in productivity or intangible costs related 
to the decreased quality of life, or informal costs. It has been estimated that informal 
costs for stroke patients and their relatives are considerable (125,126) and should be 
taken into account. However, most of the limitations are equal to both treatment 
groups and, therefore, should not influence the comparisons.  
 
6.2. Validity 
The validity (lack of systematic errors) of a study is often called internal validity.  
The internal validity is defined as the degree to which the results are representative 
for the particular population being studied (127). Randomised controlled trials are in 
general defined as trials with the highest internal validity (64). In this trial the 
conformity between the groups in the baseline data indicated that there was no 
selection bias. Blinded assessors accomplished all the tests, which should avoid some 
detection bias. A lack in the internal validity in this trial could be the use of the same 
tests several times, because the patients may be familiar with the tests, and may score 
higher on repeated measures.  
 External validity deals with whether the results are applicable in other populations 
and the extent to which the results can be generalised (127).  Despite the fact that this 
trial was defined to have high methodological quality and promising results, we 
should be careful to generalise. This trial was a single-centre trial carried out in the 
setting of a Norwegian community, were the ESD-team also was able to access high 
quality of rehabilitation service in the primary care. The history of ESD-trials is short, 
but a meta-analysis, which used the Cochrane review methods, recently, showed 
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accordance between different trials (117). However, most of the trials included only a 
part (median 41%) of stroke patients admitted to urban hospitals. Therefore the results 
of these trials may only be relevant to a proportion of patients living in a relatively 
local area and have moderate or mild stroke. In our trial we included a more 
unselected population (68%), and 22% of the excluded patients did either not have 
any functional deficit or they were unconscious ( SSS<2 or >57). So we think it is 
right to say that this trial has external validity. In comparison, thrombolytic treatment 
is applicable for about 5 % of the unselected stroke population.  
An ESD trial (128) with the same design as in our trial, carried out in 3 rural 
municipalities showed no benefit for the ESUS group, but due to a small sample size 
the trial had a lack of statistical power, and an increased  risk of uneven distribution of 
confounders. It may also be a reason that differences in the organisation of the 
primary health care system in the different municipalities play an important role for 
the benefit of an ESD intervention. 
Some considerations about validity and reliability are also described in chapter 4.7. 
 
 
 
6.3 Ethical considerations 
A clinical trial is an experiment on human beings, so there may be several important 
ethical issues relating to a clinical trial. The participants in this trial were informed 
about the nature of the trial, and signed a personal content at the time of inclusion 
(appendix 1). The informed consent might be controversial, because it is likely that 
many patients do not really understand what they are told (103). In this trial the 
patients and relatives together became the information and the participants had the 
right to withdraw from the trial and refuse any of their data at any time during the year 
if they wanted. We had some concerns about the early discharge to home in case it 
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would not be successfully. The patients in the intervention group had the right to 
return to hospital if they did not find the early discharge to home as the right decision, 
but no one did.  
The regional Ethical Committee for Medical Research evaluated the study protocol 
and approved the trial. The Norwegian Data Inspectorate approved the collecting of 
data.  
 
 
6.4. Evaluation of the results 
Paper I and II. 
For the first time it has been shown that Stroke patients that were offered early 
supported discharge service as a further development of stroke unit care, achieved 
improved short-term (26 weeks) and long-term (52 weeks) functional outcome 
compared with patients who were offered traditional stroke care. The patients were 
more likely to be independent and to be living at home. The improvement was large, 
and is in fact similar in size to the effect of thrombolytic treatment with alteplase 
within 3 hours (129), in addition to that it can be applied to almost all stroke patients. 
Similar to other ESD-trials (21), the length of institutional stay was also significantly 
reduced in our trial (40%). Other trials (37,115,116,130-133) have evaluated the 
benefits of ESD-service organised by multidisciplinary team in different ways with 
regard to functional outcome. None of them found differences in functional outcome 
after one year, and only one found a short-term significant benefit for the ESD group 
(116). The first long-term follow-up 5 years after stroke was recently published by 
Thorsén et al (134) which concluded that ESD service has a beneficial effect on 
extended ADL 5 years after stroke for patients with mild or moderate stroke.  
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There are many differences between the various trials that make the comparison 
difficult. Our design with early randomisation (within 72 hours after onset of stroke), 
initial stroke unit care for all patients in the trial and a quite unselected stroke 
population are probably strengthened for the trial. In most of the other trials patients 
with severe stroke were not included because only patients who were able to transfer 
independently from the hospital and had a carer at home were included. These 
patients probably had a relatively high functional level at baseline. 
Because we included a relative unselected stroke population, this trial give us the 
opportunity to analyse which patients that benefit most.   
We have therefore created a model to calculate the benefit of ESUS for the different 
levels of stroke severity in this trial. The results, which showed most benefit for 
patients with a baseline score between 35 and 54, can give some information about 
which patients might be given priority for such a follow-up treatment, although we 
should be very careful to generalise the results.  
 
Paper III 
The results of this paper indicate that patients who received initial stroke unit care 
combined with early supported discharge and follow-up by a mobile team report a 
better quality of life measured by global NHP at one year than patients receiving 
ordinary stroke service. Two other ESD-trials have reported the same effects, but just 
as short-term benefit (116,132). Other trials with long-term follow-up have not shown 
any differences in QoL (37,115,131). We did not find any significant difference in 
depression between the groups, although the association between depression and QoL 
are reported in earlier stroke trials (135). Nor was there any difference in social 
activity index or cognitive function between the groups, but a trend towards reduced 
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burden for the caregivers in the ESUS group. The fact that the patients in our ESUS 
group also achieved a better functional outcome (paper I and II), may contribute to 
perceive better QoL and lesser burden for the caregivers. A Swedish trial recently 
(136) showed that the caregiver’s most important determinants of QoL were their own 
age and the patients’ functional status. It has been estimated that at least 2/3 of the 
home care of the elderly is informal (125,137), so the impact the stroke has on the 
whole family is an important aspect.  
The reasons for our favourable results in the measure of QoL compared to the other 
trials remain unclear. Some of the reasons might be the fact that we had established 
more “links” and flexibility in our chain of care, which may have given a more 
complete service system and a better “safety” for the patients and their carers. There 
were no significant differences between the groups in number of contacts with the 
out-patient service, except of more use of day clinic and fewer visits from home 
nursing care in the ESUS group versus the OSUS group. 
 
Paper IV 
 This trial has shown that the total health services costs for an ESD service with early 
supported discharge and follow-up by a mobile team, are equal or less than costs for 
ordinary stroke unit care during the first year after stroke. We achieved a significant 
reduction of total in-patient days, which did not lead to an increase in costs for home-
based rehabilitation or readmissions to hospital. Some other trials have examined the 
economic consequences of ESD by comparing it with traditional care (137-142), and 
most of them found lower average costs for the ESD group. Seemingly, one of these 
trials correspond to our results (142) while some other of these trials showed lower 
average costs for both groups after one year than our trial (137,138). We have to take 
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into account the fact that the patients in these trials had a higher functional level at 
baseline, and because of that may have reduced costs compared to our patients. 
There was an increased use of outpatient rehabilitation clinic as expected, but an 
unexpected trend towards reduced use of home nursing care during the first year after 
stroke. Some other trials have measured the costs of home nursing care for stroke 
patients with opposite results (137,138). One of the reasons for the difference in 
results might be the increased functional outcome for our patients during the first year 
after stroke. 
Time is an important factor since stroke-induced disability improves or worsens with 
time. Our findings with a cost reduction for both groups over time are supported by 
results from previous descriptive studies, which concluded that the first time is the 
most expensive (143,144). The increase in cost differences in the last period from 26 
to 52 weeks (23%) are interesting, and it may indicates long-term effects on resource 
use and costs in favour of the ESD service.   
Our findings of resource use and costs according to functional outcome are important, 
but not well documented in ESD trials. The ESD- program seems to be most effective 
for patients with moderate stroke (RS 2-3 at baseline) and more expensive than 
ordinary care for patients with highest functional level (RS 0-1 at baseline). The 
reason for the fact that the costs for treating patients with mild and moderate stroke in 
our trial (table 5, paper IV) is the same, needs further investigations to be explained.   
 
6.5. Early supported discharge trialists   
The Cochrane collaboration is set up to compile all information on clinical trials, 
mainly randomized trials, within every field of medicine. One of the work groups 
according to stroke within the Cochrane stroke module is the Stroke unit trialist 
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collaboration, which consists of researches from most of the randomised stroke unit 
trials (10). Another group is the early supported discharge trialists group, co-ordinated 
by Peter Langhorne. Their first Cochrane review was published in the Cochrane 
Library in 1999 (21), and later updated. The last version was published in April 2005 
(117,145) with a meta-analysis on outcome data from 11 ESD-trials (published and 
unpublished data).  
This meta-analysis of individual patient data is an important contribution to the ESD- 
research. The generalisability increases by systematic review compared to single 
centre trials (146), and meta-analyses seems to have a high degree of evidence if the 
different trials used has high quality. Langhorne et al (117,145) showed a significant 
reduction in length of hospital stay equivalent to approximately 8 days for this 
selected group of elderly stroke patients with moderate disability (p< 0.0001). A 
reduction in death and dependency (OR 0.79, 95% CI 0.64 to 0.97) was also found in 
addition to improvement in patients’ satisfaction with services and in extended 
activities of daily living score. This corresponds to our results with 12.5 days 
reduction in institutional stay (p=0.032) and odds ratio for death or dependency 0.65 
(95% CI 0.42 – 1.01) (Figure 6). They documented the greatest benefit in trials 
evaluating a co-ordinated ESD-team (see chapter 6.6 in this thesis), and for patients 
with mild to moderate stroke.  
This meta-analysis concluded that ESD service seems to offer a promising 
contribution and effective service in addition to organised inpatient stroke unit care 
for a selected group of stroke patients with mild and moderate stroke.  
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Fig 6 
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6.6. Different ESD models.  
As previous described, there are big differences between the trials according to the 
organising and use of the ESD teams. It seems clear that patients who were early 
discharge from Hospital need some sort of support in the follow-up phase. It appears 
that early discharge from hospital without enhanced stroke service may lead to an 
increase in morbidity (147).  
But the different trials in this field have used different ways to organize their early 
supported discharge service.  Most of them are based on a multidisciplinary team 
comprising physiotherapy and occupational therapy staff with variable amounts of 
medical, nursing, and speech therapy input (112-comment). Other differences lies in 
weather they coordinate and deliver the treatment or they planned and supervised the 
treatment which been handed over to the community-based staff (117). There exist 
also differences in whether the teams have seat in the hospital (hospital based) or in 
the primary health care system (community based). 
There is a spectrum of approaches that have in common in different ways to plan and 
/or provide early post-discharge rehabilitation, co-ordinate discharge and / or hands 
over care to community services.  
 
The Early supported discharge trialists have made following classification of the ESD: 
• ESD team co-ordination and delivery: co-ordinated multidisciplinary ESD 
team co-ordinated and provided post-discharge care (37,115,116,130,131,133) 
• ESD team co-ordination: co-ordinated multidisciplinary ESD team co-
ordinated supervised discharge and immediate post-discharge care but then 
handed over to other services (132,148) 
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• No ESD team: post-discharge services were not provided by co-ordinated 
multidisciplinary ESD team (147). 
There exists no simple way to classify the different teams, which our trial exemplifies. 
Our team can be defined as a co-ordination team, which handed over care to 
community service after the early post-discharge co-ordination and organisation. 
However, for patients with more extensive needs they offered training and support in 
addition to the service from other agencies and could be categorized as a co-
ordination and delivery team.  
There exists no direct comparison between the different team models and it is in 
present not possible to conclude which team model that should be preferred. The 
organisation of the local health care service might be important for the model 
choosing.  
Table 6 shows an overview of the mobile team’s work in our trial and the frequency 
of contacts with the patients and different health service agencies. 
 
TABLE 6: Mobile team. Frequencies of contacts with patients and health service 
agencies (n=158).  
 
           Mean          Patients                     Total number     
        Contacts (n)      (n)                    (%)         of contacts 
 
 
Contacts with: 
Patient in S.U.       8.7     159   (99%)  1379 
Relatives     7.5     141   (89%)  1053 
Rehabilitation clinic    6.3       62   (39%)      388 
Home nursing care    5.5     118  (75%)      644 
Nursing Home        3.9       21   (13%)        82 
Out-patient clinic       1.2     145  (91%)      171 
Number of:  
Home visits     5.7     126   (80%)     712 
Telephone contact    5.3     130  (82%)    692 
Follow by transfer    1.4       94  (59%)    128 
Discharge meeting    1.1     134   (85%)      146 
Other contacts       3.1       53  (34%)      165 
 
Total           35     159  (99%)  5560 
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7.0  Conclusion  
 
Stroke rehabilitation has received increased attention in the past decade. When we 
started our planning in 1995, research on stroke service was concentrated about stroke 
units, and no published randomised trials existed on the follow-up research. Today 
new alternatives, as early supported discharge from hospital followed by home-based 
rehabilitation, have arisen and been carried out in several randomised trials published 
the last years. And even if this specific field so far has a short history, we begin to see 
the outlines of a more effective way to organise and accomplish the stroke 
rehabilitation after the first period of acute stroke unit care.  
This thesis with scientific methods used, will hopefully be a contribution to more 
knowledge about the benefit and effectiveness of early supported discharge service 
and organising of the follow-up after initial stroke unit care.  
 
In this thesis we have 
- constructed a stroke service system with early supported discharge in co-operation 
between the hospital and the primary health care service.  
- evaluated the short and long-term effects of this extended stroke unit service co-
ordinated by a mobile stroke team compared to traditional stroke care in terms of 
functional disability and Quality of Life. 
The results of this evaluation showed that the constructed follow-up service were 
beneficial. For the first time it was shown that stroke patients who were offered 
extended stroke unit service combined with early supported discharge, had a better 
functional outcome after 6 and 12 months of follow-up than patients offered ordinary 
stroke unit care. Subgroup analyses indicated that ESD-service were most beneficial 
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for patients with moderate severity of stroke. For the first time it was also shown that 
ESD-service also might improve the global quality of life for stroke patients 
compared to traditional stroke care. Finally, our ESD-service has like some other 
trials documented a significant reduction in length of hospital stay and length of total 
institutional stay during the first year post-stroke. 
We assessed the resource use and costs of the ESUS compared to the OSUS during 
the first year post-stroke. Our findings stating that the total costs were equal or less 
than costs for ordinary stroke unit care. The cost analyses also showed that patients 
with moderate severity of stroke had the most saving on costs, and that the difference 
in costs between the groups increased over time during the first year in favour of the 
ESUS group.  
In spite of the fact that little is known about the effect of the various components of 
the treatment provided in our trial and in other ESD trials, the importance of early, 
well organised discharge from hospital co-ordinated by a mobile team seems to be an 
important contribution in the treatment of stroke patients in addition to the initial 
stroke unit care. But we still need research in some areas to conclude for which stroke 
patients that home-based rehabilitation is preferable to hospital-based rehabilitation.  
 
Extended stroke unit service combined with early supported discharge improve 
functional outcome and improve quality of life compared to traditional stroke care. 
The costs are equal or less than costs for ordinary care. Hence, it should be 
considered, in addition to organised in-patient stroke unit care, as a part of a 
comprehensive stroke care.    
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8.  What does this thesis add: 
 
 
 
• Extended stroke unit service with early supported discharge and co-ordination 
by a mobile team improves functional outcome 6 months and 12 months after 
stroke. It was most beneficial for patients with moderate stroke. 
 
• Extended stroke unit service with early supported discharge can improve long-
term quality of life measured by global NHP, if stroke unit care is the initial 
treatment and the follow-up is co-ordinated by a mobile team. 
 
• It seems that an ESD service does not influence areas concerning the patients’ 
cognitive function, social activities and any depression. 
 
• The caregivers who got their patients early at home did not report an increased 
burden compared to caregivers whose patients became ordinary stroke unit 
care.  
 
• This trial showed that early supported discharge reduced the length of hospital 
stay with 40 %, and did also reduce the total length of institutional stay during 
the first 12 months significantly. The reduction in institutional stay did not 
lead to an increase in use of outpatient health care resources. 
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•  The total health services costs for an ESD service are equal or less than costs 
for ordinary care during the first year after stroke. The important cost savings 
caused by reduced length of institutional stay did not lead to an increased in 
costs for home-based rehabilitation. The ESD-programme seems to be most 
cost-effective for patients with moderate stroke and seems to be an expensive 
alternative for patients with mild stroke. The difference in costs increases over 
time during the first year. 
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9. Suggestions for further research  
 
 
 
 
• Different models concerning ESD service is established so far. Several  
characteristics of the ESD service are identified, but we still do not know 
which components are most important. We need more research to obtain a 
common agreement of the contents of this kind of service.  
The suggestion that particular patient groups benefit more than others also 
requires further exploration.  
 
 
 
• It seems that the co-ordinating ESD team which co-ordinate discharge and 
handed over the responsibility to other services and ESD teams that emphasize 
co-ordination and provide post-discharge care both might be effective. More 
research is needed to concretise the most suitable function for an ESD team, 
their degree of responsibility and the extent of their work.  
 
 
 
• Optimal length of follow-up for an evaluation of the efficacy of post-stroke 
rehabilitation is not known. To accumulate more evidence, future analyses 
should include long-term follow-ups.  
 
 
 
• All the randomised trials researching ESD service so far, except of one, has 
been carried out in urban communities. The effectiveness of ESD service in 
more dispersed rural municipalities has not been adequately tested. The 
information so far is limited and further research is necessary to make a final 
conclusion 
 
 
 
• Various countries and various communities organise their health care services 
in very different ways. How can variation in the clinical practice and 
organisation of the health services in the primary health care system affect the 
outcome following stroke?  
 
 
 
• Stroke imposes a great economic burden for the society and the patients. So 
far just a couple of trials (4-5) have analysed the resource use and costs 
following an ESD service. We need more research to conclude if this is a cost-
saving alternative or not. The registration of the costs of informal care that 
probably is considerable should be taken into consideration. 
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Appendix 1 
 
 
 
 
 
Pasientinformasjon. 
 
"Slagbehandlingskjeden-Trondheim" er betegnelsen på et prosjekt som støttes av 
Helse- og Sosialdepartementet. Formålet er å utvikle en behandlingskjede for 
slagpasienter i Trondheim. Vi har etter hvert utviklet relativt gode metoder for 
akuttbehandling av slagpasienter, men helsetjenestens oppfølging etter den akutte 
fase, oppleves av mange som mangelfull. Vi har derfor nå laget et opplegg for 
oppfølging av pasienter som har hatt hjerneslag, og skal prøve ut om dette fungerer 
bedre enn eksisterende tilbud. 
 
Hva betyr dette for deg som pasient? 
Pasienter fra Trondheim som er innlagt med akutt hjerneslag, blir spurt om å delta i 
prosjektet. Alle pasienter vil få det vanlige behandlingstilbudet i Slagenheten, samt en 
grundig undersøkelse etter en uke. 
 
Etter utskriving vil en gruppe pasienter få den standardoppfølging som gis i dag, men 
med et tillegg i form av en undersøkelse og spørreskjemaer etter seks uker, seks 
måneder og 12 måneder.  
 
En annen gruppe vil følges opp med ytterligere noen kontroller.  
 
Det vil så bli sammenlignet hvilke av disse opplegg som fungerer best, og som 
deltaker vil du også bli spurt om hvordan du har opplevd det tilbud som er gitt deg. På 
den måten kan du være med å gi oss kunnskap om hvilken oppfølging pasienter med 
hjerneslag trenger.  
 
Felles for alle som er med i dette prosjektet, er at ingen får et dårligere tilbud enn det 
som eksisterer i dag. 
 
Frivillig deltagelse. 
Deltagelse i dette prosjekt er frivillig, og sier du nei takk til å delta, vil du få den 
vanlige behandling som vi ellers gir til pasienter med akutt hjerneslag, men ingen 
spesiell oppfølging eller tilleggsundersøkelser etter utreise. Du vil når som helst i 
oppfølgingsperioden også kunne trekke deg fra deltagelse i prosjektet hvis du skulle 
ønske det. 
 
Pasientopplysninger. 
I forbindelse med et slikt prosjekt, må en del medisinske opplysninger samles og 
databehandles, men alle som har tilgang til opplysningene har taushetplikt. 
 
 Prosjekt ”Slagbehandlingskjeden – Trondheim” 
Slagenheten, medisinsk avdeling, Regionsykehuset i Trondheim 
 
 
 89
 
Prosjekt " Enhet for helhetlig slagbehandling" Slagenheten,  Medisinsk avdeling, RiT 
 
Pasientnavn:_________________      Prosjektlp.nr.:
  
  
         Dato for 
inklusjon:_________  
Fødselsdato:   
         Hvem har 
inkludert:_________ 
 
--------------------------------------------------------------------------------------------------------- 
Jeg har fått informasjon og er villig til å delta i studien : 
 
Sted:____________________  Dato:___________ 
 
Navn:___________________________________________ 
 
  _____________________________________ 
   pasientens underskrift 
--------------------------------------------------------------------------------------------------------- 
Jeg bekrefter at pasienten har mottatt informasjon og gitt muntlig samtykke til å delta i 
studien:1 
 
Sted:_____________________  Dato:____________ 
 
Navn:____________________________________________ 
   pårørende/vitne* 
 
  ______________________________________ 
   underskrift pårørende/vitne* 
------------------------------------------------------------------------------------------------------- 
Pasientens medisinske tilstand er slik at samtykke etter min vurdering ikke kan 
innhentes. Jeg har lest informasjonen og er enig i at pasienten deltar i studien:2  
Pasienten vil senere bli forespurt om videre deltakelse. 
 
Sted:_______________________  Dato:____________ 
 
Navn:____________________________________________ 
   pårørende/ vitne* 
  ______________________________________  
   underskrift pårørende/vitne* 
--------------------------------------------------------------------------------------------------------- 
Jeg bekrefter med dette at pasienten/pårørende/vitne* egenhendig har underskrevet på denne 
pasientinformasjonen:3 
 
 
Sted:_______________________  Dato:_____________ 
 
Lege:_____________________________________________ 
 
  underskrift av den lege som inkluderer pasienten 
--------------------------------------------------------------------------------------------------------- 
*stryk det som ikke passer. 
1) dette felt undertegnes bare hvis pasienten gir muntlig samtykke, men ikke selv kan undertegnes. 
2) dette felt undertegnes bare når pasienten ikke selv er i stand til å gi skriftlig eller muntlig samtykke. 
 90
     
 
Prosjekt "Enhet for helhetlig slagbehandling" Slagenheten, Medisinsk avdeling, Regionsykehuset i 
Trondheim. 
 
 
     "Slagbehandlingskjeden - Trondheim" 
    PASIENTINFORMASJON 
 
Det er bestemt at du skal reise hjem etter dette oppholdet i Slagenheten. 
Som deltaker i prosjekt " Slagbehandlingskjeden - Trondheim" vil du få et ekstra 
tilbud fra helsevesenets side. 
 
I Slagenheten. 
Under oppholdet her vil du få kontakt med et såkalt "ambulerende team" før 
utreise.Dette teamet vil ha oppgaver både i Slagenheten og utenfor sykehuset,og vil 
sammen med deg og dine pårørende være  med på å planlegge hjemreisen. Dagen før 
du reiser hjem vil du få en utskrivingssamtale med lege . Der vil du kunne ha med deg 
dine pårørende om du ønsker det. 
Vi ønsker også i dette prosjektet å se hvor ofte du har kontakt med andre deler av 
helsevesenet, f.eks. legebesøk.Du vil få med deg et skjema hjem som du skal fylle 
ut.Dette vil du få innføring i. 
 
Etter utskrivning fra Slagenheten. 
Etter en uke vil du bli oppringt hjemme av en som kjenner deg fra Slagenheten .  
Hvis det skulle vise seg at ting ikke fungerer som forventet etter utskrivning fra 
sykehuset,at planlagte tiltak ikke blir fulgt opp eller at nye problemer har dukket 
opp,så vil det ambulerende team følge opp dette.Det er også mulig for deg å ta direkte 
kontakt med det ambulerende team. 
 
Poliklinikk. 
Etter 1 mnd. vil du bli innkalt til en kontroll på poliklinikken her på sykehuset. Der vil 
du treffe legen fra avdelingen og den fra det ambulerende teamet som du hadde mest 
kontakt med i Slagenheten eller etter hjemreise. 
 
6 uker, 6 mnd. og 12 mnd. etter at du ble akutt syk. 
Nå får du besøk av helsepersonell hjemme som kommer til å gjøre enkelte 
undersøkelser av deg og stille deg spørsmål fra en del skjema. 
 
Pasientopplysninger. 
I forbindelse med et slikt prosjekt må en del medisinske opplysninger om deg samles 
og databehandles,men alle som har tilgang på opplysninger har taushetsplikt. 
 
Mer informasjon ? 
Vi står alltid åpne for spørsmål både for deg som pasient,og for dine nærmeste. 
 
Prosjektkontor        Prosjektleder 
Telefonnr.: 73 99 87 60.      Bent Indredavik,  
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Til .................................. 
 
I følge våre papirer på Slagenheten, Med. avd., Regionsykehuset i Trondheim, 
ble du utskrevet fra avdelingen .............................. Under sykehusoppholdet ble 
du forespurt om å være med i et prosjekt angående hjerneslagpasienter. Dette 
svarte du ja til. 
 
På Slagenheten fikk du utdelt et informasjonsskriv om dette prosjektet, hvor det 
bl.a. sto at vi  skal registrere forbruket av helsetjenester hos pasienter etter 
hjemkomst fra sykehuset.Til dette har vi utarbeidet egne blå kort, som dere 
skal benytte. 
 
Helseregistreringskortet skal fylles ut hver gang du mottar helsetjenester i form 
av f.eks. hjemmesykepleie, bruker trygghetsalarm, eller hver gang du er hos din 
primærlege eller fysioterapeut. Dette registreres ved at du skriver dato øverst på 
kortet, og setter en strek for den aktuelle tjeneste på helseregistreringskortet. 
  
I informasjonsskrivet står det at du vil bli oppsøkt av oss  6 uker og 6 måneder 
og ett år etter at du var innlagt i Slagenheten, bl.a. for at vi skal undersøke din 
motoriske funksjon og spørre deg litt om hvordan du har det i hverdagen din. 
De som kommer til deg vil kunne hjelpe deg med helseregistreringsskjemaet 
hvis du skulle ha behov for det . De vil også ta med kortene tilbake til oss 
etterhvert som de er utfyllt. 
  
Vi takker på forhånd for at du vil være med i dette 
helsetjenesteforskningsprosjektet, og med at du hjelper oss å registrere forbruk 
av helsetjenester. Dette er svært viktig for oss, for at vi skal kunne undersøke 
om slagpasienter får et tilfredsstillende tilbud også etter utskrivelse fra 
sykehuset, eller om dette må bli bedre. Den eneste måten vi kan få informasjon  
på, er at dere registrerer hva dere mottar.    
 
Skulle du ha problemer med registreringskortene, kan du ringe prosjektkontoret 
tlf.  
73 99 87 60. 
 
Med vennlig hilsen 
Hild Fjærtoft 
 prosjektkoordinator 
Prosjekt ”Slagbehandlingskjeden – Trondheim” 
Slagenheten, medisinsk avdeling, Regionsykehuset i Trondheim 
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